Accès ouvert
2025
conference-abstract
OpenAlex
Μαρία Παππά, Spyridon Katechis, M. Kosmetatou, Antigone Pieta et autres
Background: The current recommendations advocate initiating treatment for Lupus Nephritis (LN) with a lower prednisone dose, yet there is limited real-world evidence exploring the impact of initial corticosteroid dose on short-term renal outcomes in routine clinical practice. Objectives: To evaluate the initial …
gr, us
(code pays fourni par la source)
Accès ouvert
2025
conference-abstract
OpenAlex
Georgia-Savina Moysidou, Maria Grigoriou, Petros Liakopoulos, Dimitra Nikoleri et autres
Background: Belimumab, has a putative disease-modifying effect such as reduction of disease activity, risk of flares and organ damage accrual in systemic lupus erythematosus (SLE). Objectives: To characterize proteome changes upon belimumab treatment and their potential role in mediate these clinical outcomes. …
gr, de
(code pays fourni par la source)
2024
conference-abstract
OpenAlex
G. S. Moysidou, P. Garantziotis, Maria Grigoriou, Dionysis Nikolopoulos et autres
gr, de, se
(code pays fourni par la source)
Accès ouvert
2022
article
OpenAlex
G. S. Moysidou, S. Flouda, M. Kosmetatou, N. Kapsala et autres
gr
(code pays fourni par la source)
Accès ouvert
2022
conference-abstract
OpenAlex
S. Flouda, A. Grivas, N. Kapsala, Maria Grigoriou et autres
ru, gr
(code pays fourni par la source)